Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01569763 · ClinicalTrials.gov registry record · NA
Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation
A NA study of Menorrhagia, sponsored by Minerva Surgical.
- Completed
- Registry status
- NA
- Development phase
- 153
- Enrollment target
- 13
- Study locations
NCT01569763 is a NA study of Menorrhagia that has completed, run by Minerva Surgical. The registered enrollment target is 153 participants, below the 213-participant average among 10 other Menorrhagia trials with a reported enrollment target (28% lower). The trial reports 13 study locations across 11 states.
The verdict
NCT01569763, a NA study of Menorrhagia, has completed, sponsored by Minerva Surgical.
- COMPLETED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
- 13
- Study locations
Study Summary
The primary objective of this study is to evaluate the safety and effectiveness of the Aurora Endometrial Ablation System as compared to hysteroscopic rollerball endometrial ablation in reducing menstrual blood loss at 12 months post-treatment.
Conditions Studied
Interventions
- DEVICE Aurora Endometrial Ablation
- DEVICE Rollerball Ablation/Resection
Study Locations (13)
Arizona
- New Horizons Women's Care - Chandler
- Women's Health Research - Phoenix
Quebec
- La Cite Medicale - Québec
- Hôpital LaSalle - Ville Lassalle
Indiana
- Basinski, LLC - Newburgh
Kansas
- Cypress Medical Research Center, LLC - Wichita
Minnesota
- Minnesota Gynecology and Surgery - Edina
Missouri
- Mercy Clinic Minimally Invasive Gynecology - St Louis
Tennessee
- Tennessee Women's Care PC - Nashville
Texas
- Baylor Research Institute - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2012-03 |
| Est. Completion | 2018-03-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01569763
The ClinicalTrials.gov registry entry for NCT01569763 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 213-participant average among 10 other Menorrhagia trials with a reported enrollment target (28% lower). The listed sponsor is Minerva Surgical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Menorrhagia appearing as the primary indexed condition, and to 2 interventions - of which Aurora Endometrial Ablation is the first listed.
NCT01569763 reports 13 study locations spanning 11 distinct geographic areas - top geographies include Arizona, Quebec, Indiana.
Frequently Asked Questions
What is clinical trial NCT01569763 about?
NCT01569763 is a clinical study titled "Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation". The primary objective of this study is to evaluate the safety and effectiveness of the Aurora Endometrial Ablation System as compared to hysteroscopic rollerball endometrial ablation in reducing menstrual blood loss at 12 months post-treatment.
What is the current status of trial NCT01569763?
This trial is currently completed. It is a NA study. The enrollment target is 153 participants. The study started on 2012-03. Estimated completion is 2018-03-02.
What conditions does trial NCT01569763 study?
This clinical trial studies the following conditions: Menorrhagia.
What interventions are being tested in trial NCT01569763?
The interventions under investigation include: Aurora Endometrial Ablation (DEVICE), Rollerball Ablation/Resection (DEVICE).
Who is sponsoring clinical trial NCT01569763?
This trial is sponsored by Minerva Surgical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01569763 being conducted?
This trial has 13 study locations across Arizona, Indiana, Kansas, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menorrhagia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Surgical Success After Laparoscopic vs Abdominal Hysterectomy
COMPLETED · NA
-
Hysteroscopic Assessment of Fallopian Tubal Patency
COMPLETED · NA
-
Minitouch Endometrial Ablation System Treatment for Menorrhagia: An Evaluation of Safety & Effectiveness
COMPLETED · NA
-
Tranexamic Acid (TA) vs Combined Oral Contraceptive (COCP) Pilot Study
COMPLETED · NA
-
Sonography Guided Transcervical Ablation of Uterine Fibroids
COMPLETED · NA
-
A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.